“Ethics are generally not in play here”: The neutralization techniques of “the bad boy of pharma” Martin Shkreli
Abstract In 2015, the American company Turing Pharmaceuticals increased the price of the drug Daraprim by 5,000 percent overnight. Politicians and healthcare representatives accused Turing’s CEO, Martin Shkreli, of having harmed both vulnerable patient groups and the healthcare system. The present a...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | Danish |
Published: |
De Nordiske Kriminalistforeninger
2019-12-01
|
Series: | Nordisk Tidsskrift for Kriminalvidenskab |
Online Access: | https://tidsskrift.dk/NTfK/article/view/124798 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|